ArticleCancer cell2023

Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer.

Jessica E Hawley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.